In 2013, we had conducted a prospective study to evaluate the efficiency of recombinant human thrombopoietin, which has a direct effect on platelet count.[17] Confounding factors may bring in although administration of thrombopoietin in IAI patients has a limited impact on the occurrence of thrombocytopenia. Here, THPO is linked to Thrombocytopenia.